Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquartered in Helsinki, Finland.
Stock data | 2024 | Change |
---|---|---|
Price | $1.83 | N/A |
Market Cap | $143.37M | N/A |
Shares Outstanding | 78.43M | N/A |
Employees | 165.00 | N/A |